Zuo You-Mei, Gao Shan, Cao Jian-Fei, Liu Xiao-Yu, Yu Hong-Jian, Zhang Ye
Department of Anesthesiology, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Yao Xue Xue Bao. 2010 May;45(5):565-70.
The purpose of this study is to evaluate the effect of oligomeric grape seed proanthocyanidins (GSP) on isoproterenol (ISO)-induced cardiac remodeling in rats. ISO was given subcutaneously (5 mg x kg(-1), sc, 7 days) to induce cardiac remodeling in rats. Therapeutic groups were given GSP (50, 100, and 150 mg x kg(-1)) after ISO treatment. After 2 weeks intervention, heart rate (HR), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), rate of rise of left ventricular pressure (+/- dp/dt(max)) were examined. The myocardial hypertrophy index was expressed as heart weight/body weight (HW/BW) and left ventricle weight/body weight (LVW/BW), the histological changes were investigated by HE and Van Gieson stain. SOD activity and MDA content in serum, contents of hydroxyproline (Hyp) in the left ventricular tissue were assayed by xanthinoxidase method, thiobarbituric acid (TBA) method and alkaline hydrolysis method, respectively. After the onset of ISO-treatment, GSP therapy potently improved cardiac function, inhibited myocardial hypertrophy, improved cardiac pathology change, decreased the myocardial cross-section area (CSA), collagen volume fraction (CVF) and perivascular circumferential collagen area (PVCA), reduced the content of Hyp in the left ventricular tissue, inhibited the decrease of SOD activity and increase of MDA content in serum. GSP possess protective effect against ISO induced cardiac remodeling in rats, this may be related to reducing the oxidative stress and improving antioxidant capacity.
本研究旨在评估低聚葡萄籽原花青素(GSP)对异丙肾上腺素(ISO)诱导的大鼠心脏重塑的影响。皮下注射ISO(5 mg·kg⁻¹,皮下注射,共7天)以诱导大鼠心脏重塑。ISO处理后,治疗组给予GSP(50、100和150 mg·kg⁻¹)。干预2周后,检测心率(HR)、左心室收缩压(LVSP)、左心室舒张末期压力(LVEDP)、左心室压力上升速率(±dp/dt(max))。心肌肥大指数用心脏重量/体重(HW/BW)和左心室重量/体重(LVW/BW)表示,通过苏木精-伊红(HE)和范吉森(Van Gieson)染色研究组织学变化。分别采用黄嘌呤氧化酶法、硫代巴比妥酸(TBA)法和碱水解法测定血清中超氧化物歧化酶(SOD)活性、丙二醛(MDA)含量以及左心室组织中羟脯氨酸(Hyp)含量。ISO处理开始后,GSP治疗有效改善了心脏功能,抑制了心肌肥大,改善了心脏病理变化,减小了心肌横截面积(CSA)、胶原容积分数(CVF)和血管周围周向胶原面积(PVCA),降低了左心室组织中Hyp的含量,抑制了血清中SOD活性的降低和MDA含量的增加。GSP对ISO诱导的大鼠心脏重塑具有保护作用,这可能与减轻氧化应激和提高抗氧化能力有关。